MUC16 and ovarian serous adenocarcinoma: The overall test sensitivity of OVA1 in detecting ovarian malignancy has previously been reported to exceed 90% [4,6,7], while serum CA125’s high sensitivity is limited to advanced-stage, high-grade serous ovarian cancers [19,20].